Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.

× No keyword cloud information.

4 in total

Review 1. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.

Authors: D Marks; D Wonderling; M Thorogood; H Lambert; S E Humphries; H A Neil
Journal: Health Technol Assess Date: 2000 Impact factor: 4.014

2. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states.

Authors: J Slack
Journal: Lancet Date: 1969-12-27 Impact factor: 79.321

3. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.

Authors: N J Stone; R I Levy; D S Fredrickson; J Verter
Journal: Circulation Date: 1974-03 Impact factor: 29.690

4. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors:
Journal: Atherosclerosis Date: 1999-01 Impact factor: 5.162

4 in total

51 in total

1. Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractive.

Authors: J J Kastelein
Journal: BMJ Date: 2000-12-16

2. Familial hypercholesterolaemia is underdiagnosed after AMI.

Authors: M F Dorsch; R A Lawrance; N P Durham; A S Hall
Journal: BMJ Date: 2001-01-13

3. Screening for familial hypercholesterolaemia. Funding is difficult to obtain but screening can be international.

Authors: B Tomlinson; I W Lan; I Hamilton-Craig
Journal: BMJ Date: 2001-04-28

4. Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study.

Authors: Peter W Rose; Michael Murphy; Marcus Munafo; Cyril Chapman; Neil Mortensen; Anneke Lucassen
Journal: Br J Gen Pract Date: 2004-04 Impact factor: 5.386

5. Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002.

Authors: H A W Neil; T Hammond; D Mant; S E Humphries
Journal: BMJ Date: 2004-02-28

6. A model of care for familial hypercholesterolaemia: key role for clinical biochemistry.

Authors: Gerald F Watts; David R Sullivan; Frank M van Bockxmeer; Nicola Poplawski; Ian Hamilton-Craig; Peter M Clifton; Richard C O'Brien; Peter M George; John R Burnett
Journal: Clin Biochem Rev Date: 2012-02

7. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.

Authors: Leonardo De Luca; Marcello Arca; Pier L Temporelli; Furio Colivicchi; Lucio Gonzini; Donata Lucci; Biagio Bosco; Mariella Callerame; Giulio V Lettica; Andrea Di Lenarda; Michele M Gulizia
Journal: Clin Cardiol Date: 2018-08-20 Impact factor: 2.882

8. Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.

Authors: Sarah J Hardcastle; Ellen Legge; Chris S Laundy; Sarah J Egan; Rosemary French; Gerald F Watts; Martin S Hagger
Journal: Int J Behav Med Date: 2015-02

9. Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.

Authors: Roeland Huijgen; Iris Kindt; Sjoerd B J Verhoeven; Eric J G Sijbrands; Maud N Vissers; John J P Kastelein; Barbara A Hutten
Journal: PLoS One Date: 2010-02-15 Impact factor: 3.240

10. Low-density lipoprotein apheresis: an evidence-based analysis.

Authors:
Journal: Ont Health Technol Assess Ser Date: 2006-11-01